These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33274499)

  • 1. Katanin P60 and P80 in papillary thyroid carcinoma patients: Indicators for exacerbated tumor features and worse disease-free survival.
    Chen Q; Lin F; Lin E; Huang Q; Wu G
    J Clin Lab Anal; 2020 Dec; 34(12):e23502. PubMed ID: 33274499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Katanin subunits p60 and p80, potential biomarkers for papillary thyroid carcinoma to distinguish nodular goiter: STROBE.
    Wu Z; Guo M; Yang J; Xiao Y; Liu W
    Medicine (Baltimore); 2022 Jun; 101(24):e29402. PubMed ID: 35713446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients.
    Zhang L; Tao H; Ke K; Ma C
    J Clin Lab Anal; 2020 Oct; 34(10):e23452. PubMed ID: 32643206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients.
    Ye Q; Zhang M; Yin Y
    J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Katanin P80 expression correlates with lymph node metastasis and worse overall survival in patients with breast cancer.
    Li X; Liu J; Shi PF; Fu P
    Cancer Biomark; 2018; 23(3):363-371. PubMed ID: 30223388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher circular RNA_0015278 correlates with absence of extrathyroidal invasion, lower pathological tumor stages, and prolonged disease-free survival in papillary thyroid carcinoma patients.
    Ding H; Wang X; Liu H; Na L
    J Clin Lab Anal; 2021 Jul; 35(7):e23819. PubMed ID: 33969549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor tissue katanin P60 expression correlates with lymph node metastasis and worse prognosis in patients with breast cancer: A cohort study.
    Zuo L; Ying JS; Zhang FC; Xu YC
    Cancer Biomark; 2018 Feb; 21(2):425-432. PubMed ID: 29103029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
    Peng W; Li W; Zhang X; Cen W; Liu Y
    J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of katanin p60:p80 complex formation.
    Rezabkova L; Jiang K; Capitani G; Prota AE; Akhmanova A; Steinmetz MO; Kammerer RA
    Sci Rep; 2017 Nov; 7(1):14893. PubMed ID: 29097679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Katanin P60: a potential biomarker for lymph node metastasis and prognosis for non-small cell lung cancer.
    Wang L; Tantai J; Zhu X
    World J Surg Oncol; 2020 Jul; 18(1):157. PubMed ID: 32631334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Katanin-p80 gene promoter characterization and regulation via Elk1.
    Selçuk E; Kırımtay K; Canbaz D; Cesur GI; Korulu S; Karabay A
    PLoS One; 2013; 8(7):e69423. PubMed ID: 23894477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structure of a Heterotetrameric Katanin p60:p80 Complex.
    Faltova L; Jiang K; Frey D; Wu Y; Capitani G; Prota AE; Akhmanova A; Steinmetz MO; Kammerer RA
    Structure; 2019 Sep; 27(9):1375-1383.e3. PubMed ID: 31353241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
    Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
    Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
    Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
    Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of katanin activity in the ciliate Tetrahymena thermophila.
    Waclawek E; Joachimiak E; Hall MH; Fabczak H; Wloga D
    Mol Microbiol; 2017 Jan; 103(1):134-150. PubMed ID: 27726198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Katanin p60 contributes to microtubule instability around the midbody and facilitates cytokinesis in rat cells.
    Matsuo M; Shimodaira T; Kasama T; Hata Y; Echigo A; Okabe M; Arai K; Makino Y; Niwa S; Saya H; Kishimoto T
    PLoS One; 2013; 8(11):e80392. PubMed ID: 24303010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and Prognostic Significance of WW Domain Binding Protein 5 Expression in Papillary Thyroid Carcinoma.
    Qian Y; Pan Z; Guo Z; Ge X; Zheng G; Cao J; Huang P; Zhu X; Zhu X; Wen Q; Ge M
    Biomed Res Int; 2019; 2019():1791065. PubMed ID: 31828091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of a monoclonal antibody against P60-katanin.
    Akkor M; Karabay A
    Hybridoma (Larchmt); 2010 Dec; 29(6):531-7. PubMed ID: 21133804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of
    Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J
    Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Ca2+ on the microtubule-severing enzyme p60-katanin. Insight into the substrate-dependent activation mechanism.
    Iwaya N; Akiyama K; Goda N; Tenno T; Fujiwara Y; Hamada D; Ikura T; Shirakawa M; Hiroaki H
    FEBS J; 2012 Apr; 279(7):1339-52. PubMed ID: 22325007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.